These Stocks Are Moving the Most Today: Metsera, Nvidia, Tesla, Rumble, MP Materials, ViaSat, Monday.com, CoreWeave, and More

The Nasdaq Composite gained over 2% Monday, pushed up by investors hopeful that the government shutdown was winding to an end ...

Metsera falls after accepting up to $10 billion sweetened buyout offer from Pfizer

Shares of Metsera fell over 15% in premarket trading on Monday, after the weight-loss drug developer accepted a sweetened ...
STAT

The $10 billion question: Will Pfizer hit it big with Metsera, or have regrets?

At a price of up to $10 billion, Pfizer has claimed victory in its bidding war against Novo Nordisk to acquire Metsera. It's ...

Pfizer's move for Metsera adds to busy year of healthcare M&A. But the sector's in a rut.

Pfizer's agreement to buy Metsera just adds to the 83 healthcare deals counted by Goldman Sachs that were above $100 million ...
PharmExec

Novo Nordisk Not Planning Increased Proposal Offer After Metsera Enters $10 Billion Amended Merger Agreement with Pfizer

On November 4, 2025, just a day after Pfizer filed its suits against Novo Nordisk and Metsera, Novo Nordisk submitted an ...
Fierce Biotech

Pfizer beats out Novo with $10B agreement to buy Metsera

After a chaotic and fierce bidding clash that only burst out into public view a little more than a week ago, Pfizer has ...

Metsera Shares Fall Premarket as Novo Throws in Towel on Bidding War

Metsera shares fell sharply in premarket trading Monday after the weight-loss drug startup struck a revised deal to be acquired by Pfizer, prompting Danish drugmaker Novo Nordisk to drop out of a ...

Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera.

Pfizer Gets Metsera: Why The $20.65 CVR Is Highly Likely To Pay Out (In Part)

Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...